You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-epileptic drugs

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Philadelphia (Blood draw)

Active, not recruiting
  • Healthy
  • Blood draw
  • Philadelphia, Pennsylvania
    The Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022

Parkinson's Disease, Overactive Bladder, Onabotulinumtoxin A Trial in Guangzhou (oral anti-Parkinson drugs and injection of

Recruiting
  • Parkinson's Disease
  • +2 more
  • oral anti-Parkinson drugs and injection of botulinum toxin
  • oral anti-Parkinson's drugs
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 16, 2023

Breast Cancer Trial in Taichung (Diclofenac)

Completed
  • Breast Cancer
  • Taichung, Taiwan
    China Medical University Hospital
Jul 18, 2022

Depressive Disorder, Major, Inflammation Trial in Amsterdam (Celecoxib 400mg, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Inflammation
  • Celecoxib 400mg
  • Placebo
  • Amsterdam, Netherlands
    Department of Psychiatry Amsterdam UMC
Sep 28, 2022

Cancer Trial in New York (Video consultation)

Recruiting
  • Cancer
  • Video consultation
  • New York, New York
    Columbia University Medical Center
Mar 17, 2022

Refractory Epilepsy Trial in Birmingham (Traditional Treatment (Group T), Ketamine Infusion (Group K))

Withdrawn
  • Refractory Epilepsy
  • Traditional Treatment (Group T)
  • Ketamine Infusion (Group K)
  • Birmingham, Alabama
    UAB Department of Anesthesiology and Perioperative Medicine
May 18, 2021

Trigger Finger Trial (Theraputic ultrasound)

Not yet recruiting
  • Trigger Finger
  • Theraputic ultrasound
  • (no location specified)
Jul 19, 2022

Epilepsy Trial (Pharmacist-led Cognitive Behavioral therapy)

Not yet recruiting
  • Epilepsy
  • Pharmacist-led Cognitive Behavioral therapy
  • (no location specified)
Sep 12, 2023

Epilepsy Trial in Lille (Pharmacist intervention, Standard of care)

Recruiting
  • Epilepsy
  • Pharmacist intervention
  • Standard of care
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Nov 8, 2022

Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

Completed
  • Multi-drug Resistant Tuberculosis
  • 18-month regimen containing 6 anti-TB drugs
  • Beijing, China
  • +19 more
Oct 10, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

Recruiting
  • Tuberculosis
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Dec 21, 2022

Malaria, Soil Transmitted Helminths, Schistosomiasis Trial in Saraya (Albendazole, Praziquantel, Amodiaquine)

Active, not recruiting
  • Malaria
  • +5 more
  • Saraya, Kedougou, Senegal
    Saraya Health Centre
Jul 12, 2022

Epilepsy and Focal Cortical Dysplasia II Trial in Seoul (Afinitor (everolimus))

Completed
  • Epilepsy and Focal Cortical Dysplasia II
  • Afinitor (everolimus)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Apr 15, 2021

Non-Alcoholic Fatty Liver Disease Trial in Giza (conventional treatment, Furosemide or other alternatives , Niaspan or other

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • conventional treatment
  • +2 more
  • Giza, October 6, Egypt
    Maha Youssif Fekry
Nov 18, 2023

Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

Not yet recruiting
  • Myeloproliferative Disorders
  • Lymphoproliferative Disorders
  • Blood collection for the evaluation of the anti-drugs sensitivity
  • Pierre-Bénite, France
  • +1 more
Mar 2, 2022

Osteoarthritis, Knee Trial in Chicago (Naproxen 500 Mg, Placebo)

Not yet recruiting
  • Osteoarthritis, Knee
  • Naproxen 500 Mg
  • Placebo
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Jun 18, 2022

Organoids Used in Clinical Treatment of Ovarian Cancer With

Recruiting
  • Ovarian Cancer
  • Organoid
    • Guangzhou, Guangdong, China
      The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Dec 14, 2021

    Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Refractory Malignant Solid Neoplasm
    • Atezolizumab
    • +5 more
    • (no location specified)
    Feb 4, 2023

    Fatty Liver Disease, Fatty Liver Trial in Giza (Itopride, conventional therapy)

    Recruiting
    • Fatty Liver Disease
    • Fatty Liver
    • Giza, Egypt
      Maha Youssif Fekry
    Jul 28, 2023

    Effectiveness and Safety of Perampanel asadd-on Treatment for

    Active, not recruiting
    • Epilepsy
    • Beijing, Beijing, China
    • +4 more
    Feb 24, 2022

    Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction Trial (Sodium Valproate 500 Mg Prolonged-Release Oral Tablet,

    Not yet recruiting
    • Epilepsy
    • +2 more
    • Sodium Valproate 500 Mg Prolonged-Release Oral Tablet
    • +2 more
    • (no location specified)
    May 20, 2023

    Bone Resorption, Stress Fracture, Bone Injury Trial in Natick (Ibuprofen 800 mg, Celecoxib 200mg, Flurbiprofen 100 mg)

    Recruiting
    • Bone Resorption
    • +2 more
    • Ibuprofen 800 mg
    • +3 more
    • Natick, Massachusetts
      United States Army Research Institute of Environmental Medicine
    Aug 19, 2022

    A Multi-center RWS of Perampanel asadd-on Treatment for

    Active, not recruiting
    • Epilepsy
    • Beijing, Beijing, China
    • +4 more
    Mar 10, 2022

    Anti-hypertensive Medications on Diagnostic Accuracy in

    Recruiting
    • Hypertension
    • Primary Aldosteronism
    • withdraw antihypertensive drugs
    • Chongqing, Chongqing, China
    • +1 more
    Feb 17, 2022